3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
14
Colonic Neoplasms
5
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Liver Neoplasms
3
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Lung Neoplasms
2
Colorectal Cancer Screening
2
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Liver Diseases
1
Hypertension
1
Hepatitis C
1
Fibrosis
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
ColoRectal Cancer Screening
1
Interventions
Blood Specimen Collection
6
Magnetic Resonance Spectroscopy
4
Tenofovir
3
Liver Transplantation
3
Specimen Handling
2
Sorafenib
2
Simvastatin
2
tremelimumab
1
sonidegib
1
sofosbuvir-velpatasvir drug combination
1
peginterferon alfa-2a
1
navitoclax
1
maltodextrin
1
hepatitis B hyperimmune globulin
1
durvalumab
1
contrast agent BR1
1
bavituximab
1
atezolizumab
1
apixaban
1
adefovir dipivoxil
1
Viusid
1
Vitamin D
1
User-Centered Design
1
Surveys and Questionnaires
1
Sunitinib
1
Spermine Synthase
1
Sonazoid
1
Sampling Studies
1
Radiotherapy
1
Radiofrequency Ablation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fibrosis
×
Patient Navigation
×
Gastrointestinal
×
Clear all
NCT06458998
2026-02-23
GTI
University of Pittsburgh
Phase NA
Enrolling by invitation
30,300 enrolled